These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
265 related items for PubMed ID: 8871163
21. Effects of anti herpetic drugs on mice with herpetic epithelial keratitis after reactivation of herpes simplex virus type 1. Itahashi M, Higaki S, Shimomura Y. Semin Ophthalmol; 2008; 23(4):241-7. PubMed ID: 18584562 [Abstract] [Full Text] [Related]
22. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus. Saijo M, Yasuda Y, Yabe H, Kato S, Suzutani T, De Clercq E, Niikura M, Maeda A, Kurane I, Morikawa S. J Med Virol; 2002 Sep; 68(1):99-104. PubMed ID: 12210436 [Abstract] [Full Text] [Related]
23. Ocular herpes simplex virus infections: reduced sensitivity to acyclovir in primary disease. Charles SJ, Gray JJ. Br J Ophthalmol; 1990 May; 74(5):286-8. PubMed ID: 2162190 [Abstract] [Full Text] [Related]
24. Acyclovir-resistant herpes simplex virus type 1 in intra-ocular fluid samples of herpetic uveitis patients. van Velzen M, Missotten T, van Loenen FB, Meesters RJ, Luider TM, Baarsma GS, Osterhaus AD, Verjans GM. J Clin Virol; 2013 Jul; 57(3):215-21. PubMed ID: 23582986 [Abstract] [Full Text] [Related]
25. Pathogenesis of acyclovir-resistant herpes simplex type 2 isolates in animal models of genital herpes: models for antiviral evaluations. Bernstein DI, Ireland J, Bourne N. Antiviral Res; 2000 Sep; 47(3):159-69. PubMed ID: 10974368 [Abstract] [Full Text] [Related]
26. Antiviral activity of a selective ribonucleotide reductase inhibitor against acyclovir-resistant herpes simplex virus type 1 in vivo. Duan J, Liuzzi M, Paris W, Lambert M, Lawetz C, Moss N, Jaramillo J, Gauthier J, Déziel R, Cordingley MG. Antimicrob Agents Chemother; 1998 Jul; 42(7):1629-35. PubMed ID: 9660995 [Abstract] [Full Text] [Related]
27. Characterization of DNA polymerase-associated acyclovir-resistant herpes simplex virus type 1: mutations, sensitivity to antiviral compounds, neurovirulence, and in-vivo sensitivity to treatment. Wang LX, Takayama-Ito M, Kinoshita-Yamaguchi H, Kakiuchi S, Suzutani T, Nakamichi K, Lim CK, Kurane I, Saijo M. Jpn J Infect Dis; 2013 Jul; 66(5):404-10. PubMed ID: 24047739 [Abstract] [Full Text] [Related]
28. Activity of 1-(2'-fluoro-2'-deoxy-beta-D-arabinofuranosyl)thymine against herpes simplex virus in cell cultures and rabbit eyes. Trousdale MD, Nesburn AB, Su TL, Lopez C, Watanabe KA, Fox JJ. Antimicrob Agents Chemother; 1983 Jun; 23(6):808-13. PubMed ID: 6311085 [Abstract] [Full Text] [Related]
29. Topical interferon alpha-2a treatment of herpes simplex keratitis resistant to multiple antiviral medications in an immunosuppressed patient. Minkovitz JB, Pepose JS. Cornea; 1995 May; 14(3):326-30. PubMed ID: 7600820 [Abstract] [Full Text] [Related]
30. HSV1 strain sensitivity in experimental rabbit keratitis: evolution under repeated topical IDU administrations. Denis J, Langlois M, Elkaim M, Amiel C, Aymard M, Huraux JM. Curr Eye Res; 1987 Jan; 6(1):39-45. PubMed ID: 3030653 [Abstract] [Full Text] [Related]
32. Acyclovir susceptibility and genetic characteristics of sequential herpes simplex virus type 1 corneal isolates from patients with recurrent herpetic keratitis. Duan R, de Vries RD, van Dun JM, van Loenen FB, Osterhaus AD, Remeijer L, Verjans GM. J Infect Dis; 2009 Nov 01; 200(9):1402-14. PubMed ID: 19795980 [Abstract] [Full Text] [Related]
33. Pathogenicity and response to topical antiviral therapy in a murine model of acyclovir-sensitive and acyclovir-resistant herpes simplex viruses isolated from the same patient. Lebel A, Boivin G. J Clin Virol; 2006 Sep 01; 37(1):34-7. PubMed ID: 16781887 [Abstract] [Full Text] [Related]
34. [In vitro sensitivity to antiviral agents of herpes simplex viruses isolated from patients with herpetic keratitis]. Mori Y, Inoue Y, Shimomura Y, Manabe R. Nippon Ganka Gakkai Zasshi; 1990 May 01; 94(5):484-7. PubMed ID: 2171305 [Abstract] [Full Text] [Related]
35. Association between sensitivity of viral thymidine kinase-associated acyclovir-resistant herpes simplex virus type 1 and virulence. Omura N, Fujii H, Yoshikawa T, Yamada S, Harada S, Inagaki T, Shibamura M, Takeyama H, Saijo M. Virol J; 2017 Mar 21; 14(1):59. PubMed ID: 28320407 [Abstract] [Full Text] [Related]
36. Topical formulations containing Trichilia catigua extract as therapeutic options for a genital and an acyclovir-resistant strain of herpes recurrent infection. Ribelato EV, Wouk J, Celestino GG, Rodrigues BCD, Darido MLG, Barboza MGL, Botura TJ, de Oliveira MC, de Andrade FG, Lonni AASG, de Mello JCP, da Rocha SPD, Faccin-Galhardi LC. Braz J Microbiol; 2023 Sep 21; 54(3):1501-1511. PubMed ID: 37338788 [Abstract] [Full Text] [Related]
37. Acyclovir Sensitivity and Neurovirulence of Herpes Simplex Virus Type 1 with Amino Acid Substitutions in the Viral Thymidine Kinase Gene, Which Were Detected in the Patients with Intractable Herpes Simplex Encephalitis Previously Reported. Inagaki T, Satoh M, Fujii H, Yamada S, Shibamura M, Yoshikawa T, Harada S, Takeyama H, Saijo M. Jpn J Infect Dis; 2018 Sep 21; 71(5):343-349. PubMed ID: 29848849 [Abstract] [Full Text] [Related]
38. Risk factors for herpes simplex virus epithelial keratitis recurring during treatment of stromal keratitis or iridocyclitis. Herpetic Eye Disease Study Group. Wilhelmus KR, Dawson CR, Barron BA, Bacchetti P, Gee L, Jones DB, Kaufman HE, Sugar J, Hyndiuk RA, Laibson PR, Stulting RD, Asbell PA. Br J Ophthalmol; 1996 Nov 21; 80(11):969-72. PubMed ID: 8976723 [Abstract] [Full Text] [Related]